Diagnostic Medical Systems's EBIT per Share for the
six
months ended in Dec. 2025 was €0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.09.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Diagnostic Medical Systems's EBIT per Share or its related term are showing as below:
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Diagnostic Medical Systems was 69.70% per year. The lowest was -46.00% per year. And the median was -19.00% per year.
XPAR:ALDMS's 3-Year EBIT Growth Rate is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 9.4 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
Diagnostic Medical Systems (XPAR:ALDMS) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Diagnostic Medical Systems EBIT per Share Related Terms
Diagnostic Medical Systems EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.09
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diagnostic Medical Systems (XPAR:ALDMS) has a EBIT per Share of €-0.09 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Diagnostic Medical Systems and its competitors. According to the industry distribution chart, Diagnostic Medical Systems ranks #999999 out of 687 companies in the Medical Devices & Instruments industry.
Is Diagnostic Medical Systems' EBIT per Share too high?
Diagnostic Medical Systems' current EBIT per Share is €-0.09. Based on the distribution chart, Diagnostic Medical Systems ranks #999999 out of 687 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Diagnostic Medical Systems has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Diagnostic Medical Systems' EBIT per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Diagnostic Medical Systems ranks #999999 out of 687 companies for EBIT per Share. This places Diagnostic Medical Systems in the lower half of its industry. The industry median EBIT per Share is 9.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.40, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Diagnostic Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diagnostic Medical Systems's current EBIT per Share is €-0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnostic Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Diagnostic Medical Systems (XPAR:ALDMS) is currently considered Fairly Valued. The stock's GF Value™ is €1.14, compared to a current price of €1.21 — trading 6.1% above its estimated fair value. The current EBIT per Share is €-0.09. Diagnostic Medical Systems' overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Diagnostic Medical Systems (XPAR:ALDMS), the current EBIT per Share is €-0.09 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Diagnostic Medical Systems (XPAR:ALDMS) Overvalued in 2026?
Based on GuruFocus' analysis, Diagnostic Medical Systems stock appears to be overvalued.
The current stock price of €1.21 is trading 6.1% above its estimated GF Value™ of €1.14.
GuruFocus considers Diagnostic Medical Systems to be Fairly Valued.
Key valuation signals for XPAR:ALDMS:
EBIT per Share: €-0.09
GF Value™: €1.14 vs. price of €1.21 (6.1% above fair value)
No single metric tells the full story. See the XPAR:ALDMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Diagnostic Medical Systems is France's company engaged in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: Radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; and the Development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.
66GF Score
Get the complete analysis for XPAR:ALDMS
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ALDMS has been successfully added to your 
